Next Article in Journal
A Psychological Point of View on Endometriosis and Quality of Life: A Narrative Review
Next Article in Special Issue
Survival Outcomes in Sinonasal Mucosal Melanoma: Systematic Review and Meta-Analysis
Previous Article in Journal
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials
Previous Article in Special Issue
Personalized Approach to Olfactory Neuroblastoma Care
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

A Pathophysiological Approach to Spontaneous Orbital Meningoceles: Case Report and Systematic Review

by
Piergiorgio Gaudioso
1,2,3,
Elia Biancoli
1,2,
Veronica Battistuzzi
1,2,
Stefano Concheri
1,2,
Tommaso Saccardo
1,2,
Sebastiano Franchella
1,2,
Giacomo Contro
1,2,4,
Stefano Taboni
1,2,5,
Elisabetta Zanoletti
1,2,
Francesco Causin
2,6,
Lorena Nico
2,6,
Joseph Domenico Gabrieli
2,6,
Roberto Maroldi
7,
Piero Nicolai
1,2 and
Marco Ferrari
1,2,8,*
1
Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neurosciences, “Azienda Ospedale Università di Padova”, University of Padua, 35128 Padua, Italy
2
Unit of Otorhinolaryngology—Head and Neck Surgery, Azienda Ospedale Università Padova, 35128 Padua, Italy
3
Oncology and Immunology (PhD Program), Department of Surgery Oncology and Gastroenterology (DiSCOG), University of Padova, 35128 Padova, Italy
4
Technology for Health (PhD Program), Department of Information Engineering, University of Brescia, 25123 Brescia, Italy
5
Artificial Intelligence in Medicine and Innovation in Clinical Research and Methodology (PhD Program), Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy
6
Section of Neuroradiology, Department of Diagnostic Imaging and Interventional Radiology, “Azienda Ospedale Università di Padova”, University of Padua, 35128 Padua, Italy
7
Division of Radiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25123 Brescia, Italy
8
Guided Therapeutics (GTx) Program International Scholarship, University Health Network (UHN), Toronto, ON M5G 2C4, Canada
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2024, 14(5), 465; https://doi.org/10.3390/jpm14050465
Submission received: 13 March 2024 / Accepted: 30 March 2024 / Published: 28 April 2024

Abstract

:
Background: Spontaneous orbital cephaloceles are a rare condition. The purpose of this study is to provide a description of a clinical case and to carry out a systematic literature review. Methods: A systematic review of the English literature published on the Pubmed, Scopus, and Web of Science databases was conducted, according to the PRISMA recommendations. Results: A 6-year-old patient was admitted for right otomastoiditis and thrombosis of the sigmoid and transverse sinuses, as well as the proximal portion of the internal jugular vein. Radiological examinations revealed a left orbital mass (22 × 14 mm) compatible with asymptomatic orbital meningocele (MC) herniated from the superior orbital fissure (SOF). The child underwent a right mastoidectomy. After the development of symptoms and signs of intracranial hypertension (ICH), endovascular thrombectomy and transverse sinus stenting were performed, with improvement of the clinical conditions and reduction of the orbital MC. The systematic literature review encompassed 29 publications on 43 patients with spontaneous orbital MC. In the majority of cases, surgery was the preferred treatment. Conclusions: The present case report and systematic review highlight the importance of ICH investigation and a pathophysiological-oriented treatment approach. The experiences described in the literature are limited, making the collection of additional data paramount.

1. Introduction

Cephaloceles represent extracranial herniations of neural tissues through a defect in the skull. They can be classified as meningoceles (MC) when the herniation involves only the meningeal membranes, or as meningoencephaloceles (MEC) when brain parenchyma is involved [1]. Depending on the location of the defect, MC/MEC have been classified by Suwanwela et al. into the occipital, cranial vault, frontoethmoidal, basal, and cranioschisis types [2]. They can occur spontaneously or be the consequence of a trauma. Spontaneous cephaloceles can be congenital (presenting either shortly after birth or, in some instances, manifesting in adulthood [3]) or acquired when a medical condition promotes herniation through weakened areas of the skull base or foramina.
Orbital cephaloceles are a rare subtype of basal MC/MEC [2]. Patients may experience symptoms such as proptosis, visual impairment [4], and pulsatile proptosis [5]. Diagnosis mainly relies on radiology, with gadolinium-enhanced magnetic resonance (MR) being the gold-standard examination, allowing differential diagnosis with orbital cystic lesions, intra-orbital tumors, and vascular malformations [6,7,8]. High-resolution bone computed tomography (CT) can be useful in the identification of the herniation point, especially when a bony defect is implied. Considering the rarity of this condition, the optimal treatment strategy for orbital MC/MEC is tailored on a case-by-case basis, which can include watch-and-scan surveillance, medical therapy, and/or surgery [9,10,11,12,13,14].
In this study, a case report of spontaneous orbital MC is described. A systematic review of the literature is also performed to analyze the existing body of evidence and to investigate the role of intracranial hypertension (ICH) in the development and management of orbital cephaloceles.

2. Materials and Methods

2.1. Case Report

The patient’s clinical documentation was reviewed to formulate the case report.

2.2. Systematic Review

A systematic review of the English literature published on the Pubmed, Scopus, and Web of Science databases was conducted, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations [15]. The literature search was performed querying the following keywords: “orbital”, “orbit”, “cephalocele”, meningoencephalocele”, and “meningocele”. Keywords were combined when searching the aforementioned databases. Reference lists of all publications were also screened. The last search was performed on 17 January 2024. Our study is being registered in PROSPERO.
Investigations were included only if all the following criteria were met: (i) studies published in English in peer-reviewed journals, (ii) studies which describe spontaneous cephalocele (MC or MEC), (iii) studies with the respected characteristics of ethical compliance and completeness in presentation in accordance with the Case Reports (CARE) guidelines [16,17] and the Joanna Briggs Institute (JBI) checklist (Supplementary Table S1) [18]. Exclusion criteria were: (i) inaccessibility to full text, (ii) articles in the form of editorials, surveys, or letters to the editor, (iii) non-human model or cadaveric studies, (iv) studies not pertinent to spontaneous orbital MC or MEC, and (v) studies lacking relevant clinical data (clinical presentation, diagnostic assessment, and treatment). Any possible disagreements about the inclusion/exclusion of investigations and their quality were resolved by a discussion among the study team members.
Included studies were analyzed to extract available data and ensure eligibility for all patients. Data extracted from each study included the symptoms, ICH assessment, herniation point of the cephalocele, surgical treatment performed (if any), medical therapy, the outcome of ocular function, and follow-up. The risk of bias was assessed for all included studies.

3. Results

3.1. Case Report

A 6-year-old child (body weight 26 kg, height 120 cm, no significant medical history) presented to the pediatric emergency department of our Institution for episodes of vomiting (12 episodes in a day) and right otalgia. In the previous days, no fever, ocular symptoms, or headache were referred. The otoscopic assessment revealed signs of purulent right otitis media, with no eardrum perforation. Laboratory blood examination showed mild neutrophilic leukocytosis (12.31 × 109/L leukocytes), and elevated C-reactive protein (152.60 mg/L). Intravenous antibiotic therapy (ceftriaxone, 100 mg/kg/day divided into two daily doses) was administered during the first day, and the child was kept under observation. The following day, the patient developed mild left eye proptosis, eyelid ptosis with periorbital edema, and drowsiness. At ophthalmologic examination, bilateral papilledema was observed (more pronounced on the left side). CT was performed (Figure 1), revealing an opacification of the right middle ear and mastoid cells and, collaterally, a 22 × 14 mm hypodense lesion in the retrobulbar intraconal space of the left orbit involving the orbital apex.
This finding was further investigated with a contrast-enhanced angiographic MR (Figure 2), which revealed signs of otomastoiditis and right venous thrombosis involving the transverse sinus, sigmoid sinus, and proximal internal jugular vein.
The left transverse sinus was found to be hypoplastic. Additionally, a 26 × 20 mm intraconal lesion was found in the left orbit (Figure 3), with homogeneous fluid content and without contrast enhancement.
The lesion showed a rat’s tail in the orbital apex towards the parasellar area, displacing the optic nerve (ON) superiorly and impressing both the inferior and medial rectus muscles. The Fluid Attenuated Inversion Recovery (FLAIR) sequence showed a hypointense signal of the orbital lesion that was coherent with the hypothesis of MC herniated through the superior orbital fissure (SOF). In light of radiological findings, coagulation disorders were investigated, revealing a heterozygous mutation in the gene for Factor V Leiden.
Medical therapy with unfractionated heparin (100 IU/kg bolus, then 10–15 IU/kg/h), acetazolamide (38.5 mg/kg/day), vancomycin (60 mg/kg/day), and metronidazole (30 mg/kg/day) was administered. Subsequently, the patient underwent right mastoidectomy (with no evidence of purulent mastoiditis) and placement of a ventilation tube in the right ear.
In the following days, clinical deterioration was observed with increasing lethargy, vomiting, worsening of bilateral papilledema, left eyelid ptosis, reduction in visual acuity (8/10 on the left side), minimal limitation in upper rotation of the left eye, and marked limitation in lateral rotation muscle of the right eye. A new contrast-enhanced angio-MR was performed (Figure 4 and Figure 5) that demonstrated a mild progression of the thrombosis alongside radiological signs of ICH including distended ON sheaths, edematous signal changes in the ONs, and empty sella.
After neuroradiological consultation, the patient underwent staged endovascular treatment (with a 1-week interval). In the first step, the right transverse and sigmoid sinuses were recanalized and a self-expandable stent was implanted to maintain a sufficient flow. A second procedure was necessary after 7 days of dual antiplatelet therapy (DAPT) and heparin due to persistent symptoms related to ICH (dizziness, cephalalgia, and left meningocele). During this procedure, intravenous manometry of the superior sagittal and transverse sinuses demonstrated a remarkable intra-extracranial pressure gradient that required the placement of a second stent into the proximal transverse sinus and angioplasty of the organized clot in the jugular bulb (Figure 6). This led to a progressive improvement in clinical conditions.
Ten days after the procedure, a contrast-enhanced CT scan showed a reduction of the orbital MC (from 26 × 20 mm to 18 × 9 mm), along with perfusion of the transverse and sigmoid sinuses and the proximal jugular vein with residual thrombus (Figure 7a). At the time of discharge, a mild deficit in the elevation of the left eye, in the right lateral rectus muscle function, and left eyelid ptosis persisted. Low molecular weight heparin (LMWH) therapy for 3 months and DAPT for 6 months were indicated. Visual function and orthoptic findings normalized within 1 week after discharge. The contrast-enhanced CT performed at 1 month after discharge (Figure 7b) showed no residual signs of venous thrombosis and a further reduction of the orbital MC (12 × 5 mm).
The latest clinical evaluation (after the 3 month follow-up) revealed a return to general baseline conditions, with the patient being asymptomatic. The subsequent contrast-enhanced MRI was scheduled within six months. The clinical course is summarized in Figure 8.

3.2. Systematic Review

The literature search retrieved 628 studies. Based on exclusion criteria, 597 of the screened studies were excluded, according to PRISMA guidelines (Figure 9).
The details of the studies that met inclusion and exclusion criteria are shown in Table 1.
The systematic review included a total of 29 studies published from 1981 to 2023, reporting on 43 patients affected by spontaneous orbital cephalocele. The clinical details are summarized in Table 1 and Table 2 and in Figure 10.
Including the case report presented herein, 34 (79.1%) patients were affected by MC and 9 (20.9%) by MEC. The ages ranged from 15 days to 82 years, while 18 (41.9%) were pediatric patients and 25 (58.1%) were adults. In 25 cases (58.1%), the MC herniated through the optic canal (OC) making it the most frequently observed point of herniation, followed by orbital roof defects (ORD), greater sphenoidal wing defects (GSWD), and SOF. Moreover, the OC herniation point was the only one described as bilateral (15 cases, 34.9%). The most commonly reported symptom was loss of vision (22 cases, 51.2%), followed by proptosis (11 cases, 25.6%), orbital content displacement (8 patients, 18.6%), periorbital swelling (8 cases, 18.6%), headache (6 patients, 13.9%), orbital pulsation (4 cases, 9.3%), orbital pain (3 patients, 7.0%), and CSF leak (1 case, 2.3%). Only two patients (4.7%) did not complain of any symptoms, as orbital MC was an incidental finding.
ICH was investigated by lumbar puncture (LP) in nine patients (20.9%): in five (11.6%) the pressure was >200 mmH2O, while in four (9.3%) outflow pressure was in the normal range. In five cases (11.6%), ICH was suspected based on clinical evaluation (headache, vomiting, abducent nerve palsy, papilledema, etc.) and radiological signs (e.g., empty sella or ON sheath dilatation), but LP was not performed. Of note, five patients (11.6%) had a documented history of neurofibromatosis type 1 (NF1), while in two patients (4.7%) NF1 was only suspected for the presence of café-au-lait spots and/or family history.
Surgical treatment was performed in 21 (48.8%) patients, of whom 15 (34.9%) received craniofacial surgery (such as bifrontal or frontotemporal craniotomy with orbital roof reconstruction). Three patients (7.0%) received a procedure aimed to reduce the ICH: two (4.7%) patients underwent cystoperitoneal shunting (one of these procedures was concomitant to craniofacial surgery) and one (2.3%) received thrombectomy with transverse sinus stenting (our case report). Both interventions led to improvement in ocular function (visual acuity and/or ocular motor function). Seven (16.3%) patients received treatment with acetazolamide only, which resulted in improvement in ocular function in 5 cases (11.6%). In the other two cases (4.7%), visual impairment persisted but did not worsen. In over half of the patients (22, 51.2%), no residual visual deficit was observed, while in 15 cases (34.9%) a permanent visual deficit (diplopia or loss of vision) was reported during follow-up.

4. Discussion

Spontaneous orbital cephalocele is a rare finding, with only 43 cases reported in the literature. The complexity of this condition highlights the necessity for a comprehensive multidisciplinary approach in both diagnosis and treatment. The systematic review presented herein revealed considerable heterogeneity in demographic characteristics, diagnostic features, and management strategies reported in the literature. Of note, the most frequent presentation described was spontaneous MC herniated through the OC, which was bilateral in more than half of patients. This finding is likely attributable to the fact that the ON sheath is an extension of all meningeal layers, thus facilitating herniation of intracranial neural tissue [41]. This interpretation aligns with the fact that MCs herniated through the OC are the only ones documented in the literature with LP opening pressure exceeding 200 mmH2O, supporting the rationale to measure ON sheath diameter as a diagnostic criterion for ICH [42,43].
Orbital cephalocele is usually a symptomatic condition, with only 2 (4.7%) incidental diagnoses. Typically, manifestations include loss of vision, proptosis, displacement of orbital content, periorbital swelling, headache, orbital pulsation, or orbital pain (Table 3). According to the systematic review presented in this article, loss of vision emerged to be more characteristic when the herniation occurs from the OC, whereas proptosis, orbital pulsation, and orbital content displacement were more typical of herniations from ORD or GSWD. In MCs/MECs herniated from the SOF, the most reported symptom was periorbital swelling, followed by proptosis and orbital content displacement (as in our case). This trend is consistent with the site of herniation: the increased occurrence of visual symptoms in OC MCs can be attributed to ON compression and ischemia, whereas periorbital swelling in MCs herniated through the SOF may be a result of compression on the superior ophthalmic vein. Interestingly, NF1 was more frequently diagnosed or suspected in patients with MC herniation from OC or GSWD. Skull base or spine MCs are described as characteristic (even if not pathognomonic) elements of NF1 [44], with frequent association with greater sphenoidal wing dysplasia (occurring in 4–11% of NF1 patients) [45]. The latter can result in the widening of orbital fissures, possibly playing a role in the herniation of MC/MEC [46,47].
The different experiences reported in the literature highlight the need for personalized approaches, tailored by a multidisciplinary group (involving head and neck surgeons, neurosurgeons, ophthalmologists, radiologists, and neuroradiologists) considering individual patient factors and disease-specific features. Surgical treatment is frequently reported in the literature, but conservative options such as watch-and-scan schedule [9,10] or medical therapy with acetazolamide [11,12] have been reported. Among surgical strategies, craniotomy or transpalpebral transorbital approaches have been described [13,14]. CSF leak is the most frequently reported postoperative complication [5].
In the case report presented herein, the role of ICH was deemed to be paramount in the pathogenesis of the MC herniation through the SOF. This was corroborated by the finding of bilateral transverse sinus disease, with the left side affected by congenital hypoplasia, and the other side by an acute thrombotic event. The pivotal role of transverse sinus stenosis in increasing intracranial pressure, particularly when bilateral, has been previously proposed in the literature [48,49,50,51]. Our case report aligns with this evidence. Currently, LP is the gold standard for diagnosis of ICH, and treatment may involve lumbar drainage (LD) [52]. However, in our case, ICH was suspected due to bilateral transverse sinus stenosis (one with thrombosis, the other with hypoplasia), accompanying symptoms, and radiological signs. Currently, MCs are not considered a strong diagnostic criterion for ICH, even in the case of transverse sinus thrombosis [53,54,55,56,57]. Nonetheless, in our case, anticoagulant treatment for transverse sinus thrombosis was preferred in place of LP or ventricular drainage, following a pathophysiological approach guided by the suspicion of ICH being determined by insufficient venous return [52]. The hypothesized mechanism of orbital MC formation appeared to be validated by its reduction after transverse sinus thrombectomy, stenting, and acetazolamide administration. This treatment not only targeted the pathogenic mechanisms contributing to ICH but also shed light on the potential reversibility of the associated MC by treating its underlying cause. The efficacy of this combined therapeutic approach corroborates the importance of understanding and addressing the underlying pathophysiological factors in the management of spontaneous orbital MC. Despite the theories supporting the role of ICH in the development of orbital cephaloceles [11,21,51,58], many previous experiences have poorly explored this aspect. Only nine studies in the literature reported diagnosis of ICH using radiologic or instrumental investigations, reflecting a gap in the understanding of orbital MC. This could have led to missing a diagnosis of ICH, opting for surgical treatment directly addressing the MC and its herniation point (such as a craniofacial approach with MC resection and orbital roof plasty [32] or frontotemporal craniotomy and repair of bone defect with partial thickness calvaria autologous bone graft [14]) with no investigation of the pathophysiological mechanism. The finding of ICH in orbital MC can support a more pathophysiology-oriented treatment approach to the underlying cause of the MC. However, the clinical presentation of intraorbital MC/MEC is heterogeneous, and at times the underlying causes remain concealed.
The current study has some limitations. The small number of patients documented in the literature precludes a meta-analysis, and the limited available data constrains a more in-depth investigation into the pathophysiological mechanisms of MC/MEC formation. Notwithstanding these limitations, we believe that the case report and insights from the systematic review should promote a more comprehensive investigation of the pathophysiology-oriented treatment modalities for spontaneous orbital cephaloceles.

5. Conclusions

This study emphasizes the heterogeneous presentation of spontaneous orbital cephaloceles and the complexity of their management. The results stress the importance of a multidisciplinary and individualized approach to diagnosis and management. The insights from both the systematic review and the case report support the importance of considering ICH and associated anatomical factors in the management of this rare pathological condition. Moreover, the the importance and possible advantages of treating the underlying cause of spontaneous orbital cephaloceles are highlighted.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jpm14050465/s1, Table S1: Assessment of ethical compliance and completeness in the presentation of the 29 selected articles in accordance with the Joanna Briggs Institute (JBI) checklist.

Author Contributions

Conceptualization: P.G., E.B. and M.F.; methodology: P.G. and M.F.; investigation: P.G., E.B., S.C., V.B. and T.S.; data curation: P.G., S.C., V.B. and T.S.; writing—original draft preparation: P.G., E.B., S.C., V.B. and T.S.; writing—review and editing: G.C., S.T., E.Z., F.C., L.N., J.D.G., M.F. and S.F.; visualization, R.M. and P.N.; supervision: M.F., S.F. and P.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The Study was conducted in accordance with the principles of the Helsinki Declaration, the Italian privacy and data laws, and the in-house rules for retrospective studies of the Otolaryngology Section at Padova University (Italy). The patient’s tutor signed a detailed informed consent form regarding the processing and publication of their data. They consented to “the use of the clinical data for scientific research purposes in the medical, biomedical and epidemiological fields, also in order to be recalled in the future for follow-up needs”. The data were examined in agreement with the Italian privacy and sensitive data laws, and the internal regulations of the University of Padova.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Flint, P.W.; Haughey, B.H.; Lund, V.J.; Robbins, K.T.; Thomas, J.R.; Lesperance, M.M.; Francis, H.W. Cummings Otolaryngology–International Edition: Head and Neck Surgery. 2020, Volume 7, pp. 1323–1344. Available online: https://www.worldcat.org/title/1239324944 (accessed on 19 January 2024).
  2. Suwanwela, C.; Suwanwela, N. A morphological classification of sincipital encephalomeningoceles. J. Neurosurg. 1972, 36, 201–211. [Google Scholar] [CrossRef] [PubMed]
  3. Van Rumund, A.; Verrips, A.; Verhagen, W.I.M. Pulsatile Proptosis due to Intraorbital Meningocele. Front. Neurol. 2017, 8, 290. [Google Scholar] [CrossRef] [PubMed]
  4. Sadashivam, S. Isolated Orbital Roof Fracture: Can It Be Catastrophic? Asian J. Neurosurg. 2018, 13, 935. [Google Scholar] [CrossRef] [PubMed]
  5. Gelabert-González, M.; García-Allut, A.; Villa, J.F.; Martínez-Rumbo, R. Orbital meningocystocele. Neurocirugia 2003, 14, 145–147; discussion 148. [Google Scholar] [CrossRef] [PubMed]
  6. Yan, J.; Li, Y.; Chen, Q.; Ye, X.; Li, J. Rare orbital cystic lesions in children. J. Craniomaxillofac. Surg. 2014, 43, 238–243. [Google Scholar] [CrossRef] [PubMed]
  7. Pahwa, S.; Sharma, S.; Das, C.J.; Dhamija, E.; Agrawal, S. Intraorbital Cystic Lesions: An Imaging Spectrum. Curr. Probl. Diagn. Radiol. 2015, 44, 437–448. [Google Scholar] [CrossRef] [PubMed]
  8. Kaufman, L.M.; Villablanca, J.P.; Mafee, M.F. Diagnostic imaging of cystic lesions in the child’s orbit. Radiol. Clin. N. Am. 1998, 36, 1149–1163. [Google Scholar] [CrossRef] [PubMed]
  9. Sioufi, K.; Say, E.A.T.; Gray, H.M.; Shields, C.L. Optic nerve Meningocele simulating extraocular extension of choroidal melanoma. Retin. Cases Brief. Rep. 2017, 11, S174–S177. [Google Scholar] [CrossRef] [PubMed]
  10. Downey, E.F.D., Jr.; Weinstein, Z.R. Unusual case of orbital encephalocele. AJNR Am. J. Neuroradiol. 1984, 5, 199–200. [Google Scholar]
  11. Morello, A.; Bianconi, A.; Cogoni, M.; Borgarello, S.; Garbossa, D.; Micon, B.M. Bilateral idiopathic optic nerve sheath meningocele: A case report and literature review. J. Neurosci. Rural Pract. 2022, 13, 781. [Google Scholar] [CrossRef]
  12. Jain, D.H.; Noronha, V.O.; Mukherjee, B. Optic Nerve Sheath Meningocele with Optic Disc Pit: A Rare Finding. Ophthalmic Plast. Reconstr. Surg. 2019, 35, E85. [Google Scholar] [CrossRef] [PubMed]
  13. Peto, I.; Molcanyi, M.; Noureldine, M.H.A.; Bajric, J.; Agazzi, S. Transpalpebral transorbital neuroendoscopic (TONES) repair of orbital meningoencephalocele: A technical note. Br. J. Neurosurg. 2023, 37, 1904–1908. [Google Scholar] [CrossRef]
  14. Trivedi, A.; Garg, A.K.; Hiran, S. Partial thickness autologus calvarial bone orbitocranioplasty for a sphenorbital encephalocele presenting as pulsatile exophthalmos. Asian J. Neurosurg. 2015, 10, 119–122. [Google Scholar] [CrossRef] [PubMed]
  15. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef] [PubMed]
  16. Riley, D.S.; Barber, M.S.; Kienle, G.S.; Aronson, J.K.; von Schoen-Angerer, T.; Tugwell, P.; Kiene, H.; Helfand, M.; Altman, D.G.; Sox, H.; et al. CARE guidelines for case reports: Explanation and elaboration document. J. Clin. Epidemiol. 2017, 89, 218–235. [Google Scholar] [CrossRef] [PubMed]
  17. Gagnier, J.J.; Kienle, G.; Altman, D.G.; Moher, D.; Sox, H.; Riley, D. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob. Adv. Health Med. 2013, 2, 38. [Google Scholar] [CrossRef] [PubMed]
  18. Aromataris, E.; Lockwood, C.; Porritt, K.; Pilla, B.; Jordan, Z. (Eds.) Chapter 7: Systematic reviews of etiology and risk. In JBI Manual for Evidence Synthesis; Joanna Briggs Institute Reviewer’s Manual; Joanna Briggs Institute: Adelaide, Australia, 2020. [Google Scholar] [CrossRef]
  19. Weizman, Z.; Tenembaum, A.; Perlman, M.; Sahar, A. Orbital meningocele presenting as periorbital cellulitis. Childs Brain 1981, 8, 207–210. [Google Scholar] [CrossRef] [PubMed]
  20. Bornemann, A.; Schwarz, M.; Brühl, K.; Goebel, H.H. A sphenoorbital encephalocele–clinical, radiological, and morphological findings. Neurosurg. Rev. 1988, 11, 205–206. [Google Scholar] [CrossRef] [PubMed]
  21. Garrity, J.A.; Trautmann, J.C.; Bartley, G.B.; Forbes, G.; Bullock, J.D.; Jones, T.W.; Waller, R.R. Optic Nerve Sheath Meningoceles: Clinical and Radiographic Features in 13 Cases with a Review of the Literature. Ophthalmology 1990, 97, 1519–1531. [Google Scholar] [CrossRef]
  22. Sugawara, Y.; Harii, K.; Hirabayashi, S.; Sakurai, A.; Sasaki, T. A spheno-orbital encephalocele with unilateral exophthalmos. Ann. Plast. Surg. 1996, 36, 410–412. [Google Scholar] [CrossRef]
  23. Lunardi, P.; Farah, J.O.; Ruggeri, A.; Nardacci, B.; Ferrante, L.; Puzzilli, F. Surgically verified case of optic sheath nerve meningocele: Case report with review of the literature. Neurosurg. Rev. 1997, 20, 201–205. [Google Scholar] [CrossRef] [PubMed]
  24. Shanmuganathan, V.; Leatherbarrow, B.; Ansons, A.; Laitt, R. Bilateral idopathic optic nerve sheath meningocele associated with unilateral transient cystoid macular oedema. Eye 2002, 16, 800–802. [Google Scholar] [CrossRef] [PubMed]
  25. Mesa-Gutiérrez, J.C.; Quiñones, S.M.; Ginebreda, J.A. Optic nerve sheath meningocele. Clin. Ophthalmol. 2008, 2, 661. [Google Scholar] [CrossRef] [PubMed]
  26. Knopp, U.; Knopp, A.; Stellmacher, F.; Reusche, E.; Löning, M.; Kantelhardt, S.R.; von Domarus, H.; Arnold, H.; Giese, A. A non-midline spheno-orbital encephalocele in a newborn. Cent. Eur. Neurosurg. 2009, 70, 43–47. [Google Scholar] [CrossRef] [PubMed]
  27. Spooler, J.C.; Cho, D.; Ray, A.; Zouros, A. Patient with congenital optic nerve meningocele presenting with left orbital cyst. Childs Nerv. Syst. 2008, 25, 267–269. [Google Scholar] [CrossRef] [PubMed]
  28. Ahmed, A.; Noureldin, R.; Gendy, M.; Sakr, S.; Naby, M.A. Antenatal sonographic appearance of a large orbital encephalocele: A case report and differential diagnosis of orbital cystic mass. J. Clin. Ultrasound 2012, 41, 327–331. [Google Scholar] [CrossRef] [PubMed]
  29. Halimi, E.; Wavreille, O.; Rosenberg, R.; Bouacha, I.; Lejeune, J.-P.; Defoort-Dhellemmes, S. Optic Nerve Sheath Meningocele: A Case Report. Neuroophthalmology 2013, 37, 78–81. [Google Scholar] [CrossRef] [PubMed]
  30. Sharma, M.; Mally, R.; Velho, V.; Agarwal, V. Spheno-orbital encephalocele: A rare entity—A case report and review of literature. Asian J. Neurosurg. 2014, 9, 108. [Google Scholar] [CrossRef] [PubMed]
  31. Germano, R.A.S.; Silva, M.V.; Germano, F.A.S.; Brandão, M.M.; Germano, C.S.; de Souza, B.L.; Kawai, R.M.; Germano, J.E. Eyelid liquoric fistula secondary to orbital meningocele. Rev. Bras. Oftalmol. 2015, 74, 46–48. [Google Scholar] [CrossRef]
  32. Hoang, A.; Maugans, T.; Ngo, T.; Ikeda, J. Nontraumatic orbital roof encephalocele. J. AAPOS 2016, 21, 81–83. [Google Scholar] [CrossRef]
  33. Mahatma, G.; Sadaka, A.; Berry, S.; Malik, A.; Lee, A.G. Stabilization of visual function after optic nerve sheath fenestration for optic nerve meningocele. Ophthalmic Plast. Reconstr. Surg. 2017, 33, e160–e161. [Google Scholar] [CrossRef] [PubMed]
  34. Algarni, M.; Maralani, P.J.; Sundaram, A.N.E. Optic nerve sheath meningocele. Int. Med. Case Rep. J. 2018, 11, 213. [Google Scholar] [CrossRef] [PubMed]
  35. Shaikh, M.; Khera, P.; Yadav, T.; Garg, P. Dural Ectasia of the Optic Nerve: A Rare Presentation in Neurofibromatosis Type I. J. Neurosci. Rural Pract. 2019, 10, 349–351. [Google Scholar] [CrossRef] [PubMed]
  36. Zurita, M.; Candanedo, C.; Moscovici, S.; Kaye, A.H.; Spektor, S. Spontaneous symptomatic orbital meningoencephalocele in an adult patient. Case report and review of the literature. J. Clin. Neurosci. 2020, 77, 224–226. [Google Scholar] [CrossRef]
  37. Mbaye, M.; Thiam, A.B.; Cissue, M.A.; Faye, M.; Ndiaye, S.Y.E.H.C.; Thioub, M.; Ndoye, N.; Ba, M.C.; Badiane, S.B. Orbital meningocele in two case studies. Surg. Neurol. Int. 2020, 11, 119. [Google Scholar] [CrossRef] [PubMed]
  38. Kulkarni, V.M.; Chitalkar, S.B.; Khaladkar, S.M.; Navani, R.S.; Lamghare, P. Arachnoid Cyst in Middle Cranial Fossa with Intraorbital Cyst (Orbital Meningocele). Cureus 2021, 13, e18795. [Google Scholar] [CrossRef] [PubMed]
  39. Lai, Y.-F.; Lee, L.-C.; Chen, Y.-H.; Chien, K.-H. Pulsating proptosis and heavy eye syndrome precipitated by neurofibromatosis type 1: A case report. Medicine 2021, 100, e27575. [Google Scholar] [CrossRef] [PubMed]
  40. Rajabi, M.T.; Mohammadi, A.; Besharati, S. Proptosis due to Isolated Intra-orbital Meningocele-a case Report. Case Rep. Clin. Pract. 2023, 8, 42–45. [Google Scholar] [CrossRef]
  41. Geeraerts, T.; Newcombe, V.F.; Coles, J.P.; Abate, M.G.; E Perkes, I.; Hutchinson, P.J.; Outtrim, J.G.; A Chatfield, D.; Menon, D.K. Use of T2-weighted magnetic resonance imaging of the optic nerve sheath to detect raised intracranial pressure. Crit. Care 2008, 12, R114. [Google Scholar] [CrossRef]
  42. Wang, J.; Li, K.; Li, H.; Ji, C.; Wu, Z.; Chen, H.; Chen, B. Ultrasonographic optic nerve sheath diameter correlation with ICP and accuracy as a tool for noninvasive surrogate ICP measurement in patients with decompressive craniotomy. J. Neurosurg. 2019, 133, 514–520. [Google Scholar] [CrossRef]
  43. Munawar, K.; Khan, M.T.; Hussain, S.W.; Qadeer, A.; Shad, Z.S.; Bano, S.; Abdullah, A. Optic Nerve Sheath Diameter Correlation with Elevated Intracranial Pressure Determined via Ultrasound. Cureus 2019, 11, e4145. [Google Scholar] [CrossRef] [PubMed]
  44. Russo, C.; Russo, C.; Cascone, D.; Mazio, F.; Santoro, C.; Covelli, E.M.; Cinalli, G. Non-oncological neuroradiological manifestations in nf1 and their clinical implications. Cancers 2021, 13, 1831. [Google Scholar] [CrossRef] [PubMed]
  45. Naran, S.; Swanson, J.W.; Ligh, C.A.; Shubinets, V.; Taylor, J.A.; Bartlett, S.P. Sphenoid dysplasia in neurofibromatosis: Patterns of presentation and outcomes of treatment. Plast. Reconstr. Surg. 2018, 142, 518E–526E. [Google Scholar] [CrossRef] [PubMed]
  46. Viskochil, D.H.; Stevenson, D.A. Skeletal Manifestations in NF1. Multidisciplinary Approach to Neurofibromatosis Type 1, Springer: Cham, Switzerland, 2020; 85–99. [Google Scholar] [CrossRef]
  47. Chapman, P.H.; Curtin, H.D.; Cunningham, M.J. An unusual pterygopalatine meningocele associated with neurofibromatosis type 1. Case report. J. Neurosurg. 2000, 93, 480–483. [Google Scholar] [CrossRef] [PubMed]
  48. Bedarida, V.; Labeyrie, M.; Eliezer, M.; Saint-Maurice, J.; Jourdaine, C.; Gargalas, S.; Herman, P.; Houdart, E.; Verillaud, B. Association of spontaneous cerebrospinal fluid rhinorrhea with transverse venous sinus stenosis: A retrospective matched case-control study. Int. Forum Allergy Rhinol. 2020, 10, 1295–1299. [Google Scholar] [CrossRef] [PubMed]
  49. Morris, P.P.; Black, D.F.; Port, J.; Campeau, N. Transverse Sinus Stenosis Is the Most Sensitive MR Imaging Correlate of Idiopathic Intracranial Hypertension. AJNR Am. J. Neuroradiol. 2017, 38, 471. [Google Scholar] [CrossRef] [PubMed]
  50. Millán, D.S.; Hallak, B.; Wanke, I.; Wetzel, S.; Van Dommelen, K.; Rüfenacht, D.; Gailloud, P. Dural venous sinus stenting as a stand-alone treatment for spontaneous skull base CSF leak secondary to venous pseudotumor cerebri syndrome. Neuroradiology 2019, 61, 1103–1106. [Google Scholar] [CrossRef] [PubMed]
  51. Zhao, K.; Gu, W.; Liu, C.; Kong, D.; Zheng, C.; Chen, W.; Li, X.; Liang, Y.; Zhou, H. Advances in the Understanding of the Complex Role of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension. J. Magn. Reson. Imaging 2022, 56, 645. [Google Scholar] [CrossRef] [PubMed]
  52. Lele, A.V.; Hoefnagel, A.L.; Schloemerkemper, N.; Wyler, D.A.; Chaikittisilpa, N.; Vavilala, M.S.; Naik, B.I.; Williams, J.H.; Raghavan, L.V.; Koerner, I.P. Perioperative management of adult patients with external ventricular and lumbar drains: Guidelines from the society for neuroscience in anesthesiology and critical care. J. Neurosurg. Anesthesiol. 2017, 29, 191–210. [Google Scholar] [CrossRef]
  53. Ferro, J.M.; Bousser, M.-G.; Canhão, P.; Coutinho, J.M.; Crassard, I.; Dentali, F.; di Minno, M.; Maino, A.; Martinelli, I.; Masuhr, F.; et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-Endorsed by the European Academy of Neurology. Eur. Stroke J. 2017, 2, 195–221. [Google Scholar] [CrossRef]
  54. Wei, H.; Jiang, H.; Zhou, Y.; Liu, L.; Zhou, C.; Ji, X. Intracranial hypertension after cerebral venous thrombosis—Risk factors and outcomes. CNS Neurosci. Ther. 2023, 29, 2540–2547. [Google Scholar] [CrossRef] [PubMed]
  55. Ferro, J.M.; Bousser, M.-G.; Canhão, P.; Coutinho, J.M.; Crassard, I.; Dentali, F.; di Minno, M.; Maino, A.; Martinelli, I.; Masuhr, F.; et al. Idiopathic intracranial hypertension: Consensus guidelines on management. J. Neurol. Neurosurg. Psychiatry 2018, 89, 1088–1100. [Google Scholar] [CrossRef]
  56. Nicholson, P.; Brinjikji, W.; Radovanovic, I.; Hilditch, C.A.; Tsang, A.C.O.; Krings, T.; Pereira, V.M.; Lenck, S. Venous sinus stenting for idiopathic intracranial hypertension: A systematic review and meta-analysis. J. Neurointerventional Surg. 2019, 11, 380–385. [Google Scholar] [CrossRef] [PubMed]
  57. Malem, A.; Sheth, T.; Muthusamy, B. Paediatric Idiopathic Intracranial Hypertension (IIH)-A Review. Life 2021, 11, 632. [Google Scholar] [CrossRef]
  58. Bialer, O.Y.; Rueda, M.P.; Bruce, B.B.; Newman, N.J.; Biousse, V.; Saindane, A.M. Meningoceles in idiopathic intracranial hypertension. AJR Am. J. Roentgenol. 2014, 202, 608–613. [Google Scholar] [CrossRef]
Figure 1. (A): CT without contrast agent administration shows an intra-orbital retrobulbar fluid-density sac (white arrows) on the left side. Posteriorly the fluid-filled sac replaces the fat tissue in the superior orbital fissure. The left cavernous sinus (arrowheads) is filled by a low density, similar to the intra-orbital sac. (B): the right middle ear is filled with fluid (black arrows).
Figure 1. (A): CT without contrast agent administration shows an intra-orbital retrobulbar fluid-density sac (white arrows) on the left side. Posteriorly the fluid-filled sac replaces the fat tissue in the superior orbital fissure. The left cavernous sinus (arrowheads) is filled by a low density, similar to the intra-orbital sac. (B): the right middle ear is filled with fluid (black arrows).
Jpm 14 00465 g001
Figure 2. Post-contrast MR fused with MR venography (AC) and MR venography (BD). (A,B): thrombosis of the right transverse sinus (1), venography detects residual flow along its anterior wall (2). The left transverse sinus (TS) is hypoplastic. A prominent superior ophthalmic vein is shown on the right side (SOV). The left optic nerve (ON) is displaced by the intraorbital meningocele (M). (C,D): Fluid collection at the right mastoid with thrombosis of the sigmoid sinus (SS) and internal jugular vein (IJV). The right inferior petrosal sinus is patent (IPS). ICA: internal carotid artery.
Figure 2. Post-contrast MR fused with MR venography (AC) and MR venography (BD). (A,B): thrombosis of the right transverse sinus (1), venography detects residual flow along its anterior wall (2). The left transverse sinus (TS) is hypoplastic. A prominent superior ophthalmic vein is shown on the right side (SOV). The left optic nerve (ON) is displaced by the intraorbital meningocele (M). (C,D): Fluid collection at the right mastoid with thrombosis of the sigmoid sinus (SS) and internal jugular vein (IJV). The right inferior petrosal sinus is patent (IPS). ICA: internal carotid artery.
Jpm 14 00465 g002
Figure 3. (AF): The coronal T2 sequence shows the intraorbital meningocele (M) displacing the optic nerve (ON) upward and medially (A). A prominent subarachnoid space at the level of both optic sheaths is present. The meningocele enters the orbit via the superior orbital fissure (SOF) (B). At the anterior aspect of the cavernous sinus (C), the meningocele runs below the anterior clinoid (AC) and above the maxillary groove of the maxillary nerve (V2); it displaces the lateral wall of the cavernous sinus (DF), causing a more convex shape (CS). At the posterior aspect of the cavernous sinus, the fluid signal is present both medially to the left internal carotid artery (white arrow) and laterally. The left oculomotor nerve runs in a lower position (IIIn) than the right one.
Figure 3. (AF): The coronal T2 sequence shows the intraorbital meningocele (M) displacing the optic nerve (ON) upward and medially (A). A prominent subarachnoid space at the level of both optic sheaths is present. The meningocele enters the orbit via the superior orbital fissure (SOF) (B). At the anterior aspect of the cavernous sinus (C), the meningocele runs below the anterior clinoid (AC) and above the maxillary groove of the maxillary nerve (V2); it displaces the lateral wall of the cavernous sinus (DF), causing a more convex shape (CS). At the posterior aspect of the cavernous sinus, the fluid signal is present both medially to the left internal carotid artery (white arrow) and laterally. The left oculomotor nerve runs in a lower position (IIIn) than the right one.
Jpm 14 00465 g003
Figure 4. The sagittal T1 sequence shows the sella turcica filled by CSF with a distinct concavity of the hypophysis.
Figure 4. The sagittal T1 sequence shows the sella turcica filled by CSF with a distinct concavity of the hypophysis.
Jpm 14 00465 g004
Figure 5. In the two T2 axial planes, the CSF signal is detected within the cavernous sinus, both medially and laterally to the internal carotid artery (white arrows on (A)). (B): The cisternal segment of the trigeminal nerve is eccentric with respect to the Meckel cave. A separation of the Meckel cave and cavernous sinus is not detectable, and the path of the CSF signal runs toward the superior orbital fissure ending in the intraorbital meningocele (black arrows).
Figure 5. In the two T2 axial planes, the CSF signal is detected within the cavernous sinus, both medially and laterally to the internal carotid artery (white arrows on (A)). (B): The cisternal segment of the trigeminal nerve is eccentric with respect to the Meckel cave. A separation of the Meckel cave and cavernous sinus is not detectable, and the path of the CSF signal runs toward the superior orbital fissure ending in the intraorbital meningocele (black arrows).
Jpm 14 00465 g005
Figure 6. Arteriography with venous phase. (A): Selective injection in the right ICA, a stent has been placed inside the right transverse sinus. (B): Patency of the stent is demonstrated. Residual stenosis of the right transverse sinus at the origin (white arrows). Hypoplastic left transverse sinus with faint contrast agent filling of the left jugular vein (black arrows). (C): The oblique view demonstrates a residual thrombus at the origin of the right jugular vein.
Figure 6. Arteriography with venous phase. (A): Selective injection in the right ICA, a stent has been placed inside the right transverse sinus. (B): Patency of the stent is demonstrated. Residual stenosis of the right transverse sinus at the origin (white arrows). Hypoplastic left transverse sinus with faint contrast agent filling of the left jugular vein (black arrows). (C): The oblique view demonstrates a residual thrombus at the origin of the right jugular vein.
Jpm 14 00465 g006
Figure 7. (A): CT obtained a few days after placement of the right transverse sinus stent shows residual thrombus (black arrow) and a reduction in the size of the intraorbital meningocele (white arrows). (B): At follow-up CT acquired after one month, complete patency of sigmoid sinus is achieved (black arrow). A further reduction in the size of the meningocele is shown (white arrows).
Figure 7. (A): CT obtained a few days after placement of the right transverse sinus stent shows residual thrombus (black arrow) and a reduction in the size of the intraorbital meningocele (white arrows). (B): At follow-up CT acquired after one month, complete patency of sigmoid sinus is achieved (black arrow). A further reduction in the size of the meningocele is shown (white arrows).
Jpm 14 00465 g007
Figure 8. The clinical course of the patient.
Figure 8. The clinical course of the patient.
Jpm 14 00465 g008
Figure 9. PRISMA flowchart illustrating the article selection process.
Figure 9. PRISMA flowchart illustrating the article selection process.
Jpm 14 00465 g009
Figure 10. Bar plots of general characteristics of the systematic review: (A) ICH assessment; (B) herniation point; (C) surgery or interventional procedures performed; (D) outcome of ocular function.
Figure 10. Bar plots of general characteristics of the systematic review: (A) ICH assessment; (B) herniation point; (C) surgery or interventional procedures performed; (D) outcome of ocular function.
Jpm 14 00465 g010
Table 1. Studies included in the systematic review.
Table 1. Studies included in the systematic review.
Publication (First Author, Year)Number of CasesAgeGenderSideDiagnosisIch Erniation Point IdentificationSurgery
or IP
Medical Treatment for IchAssociated Medical Conditions
Weizman, 1981 [19]115 days FUMCNon suspORDYesYes
Downey, Jr, 1983 [10]11 year MUMECNon suspSOFNoNoContralateral retinoblastoma
Bornemann, 1988 [20]1Pediatric NOSMUMECNon suspSOFYes
Garrity, 1990 [21]133–61 years
(3 pediatrics NOS)
7M
6F
11 B
2 U
13 MC2 Yes
1 Susp
10 Non susp
13 OC3 Yes
10 No
3 NF1
Sugawara, 1995 [22]15 yearsMUMECNon suspGSWDYes Suspected NF1
Lunardi, 1997 [23]115 yearsMUMCNoOCYes
Shanmuganathan, 2002 [24]159 years MBMCYesOCNo
Mesa-Gutiérrez, 2008 [25]153 yearsMUMCYesOCNoAcetazolami (250 mg ×2)
Knopp, 2009 [26]14 daysMUMECNon suspGSWDYes
Spooler, 2009 [27]15 yearsMUMCSuspOCYes Multiple malformations
Ahmed, 2012 [28]1Prenatal periodFUMEC SOFYesNo
Halimi, 2013 [29]139 yearsFUMCSuspOCNoAcetazolami (125 mg ×2–3)
Sharma, 2014 [30]122 yearsMUMECNon suspGSWDYes
Germano, 2015 [31]151 yearsFUMCNon suspORDYes
Trivedi, 2015 [14]110 yearsFUMCNoGSWDYes Suspected NF1
Van Rumund, 2017 [3]179 yearsMUMCNon suspORDNo
Hoang, 2017 [32]13 yearsFUMECNon suspORDYesNo
Mahatma, 2017 [33]110 yearsMBMCSuspOCYes
Sioufi, 2017 [9]153 yearsMBMCNon suspOCNoNoLeft choroidal melanoma
Algarni, 2018 [34]282 years
53 years
1 M
1 F
2 U2 MC1 Yes
1 No
2 OC2 No
Jain, 2019 [12]113 yearsFUMCNon suspOCNoAcetazolami (250 mg)
Shai kh, 2019 [35]120 yearsFUMCNon suspOCNo NF1
Zurita, 2020 [36]141 yearsFUMECNon suspNoYes
Mbaye, 2020 [37]17 yearsFUMCNon suspNoYesAcetazolami (250 mg)
Kulkarni, 2021 [38]120 yearsMUMC ORDYes
Peto, 2021 [13]150 yearsMUMEC ORDYes
Lai, 2021 [39]141 yearsFUMC GSWDYes NF1
Morello, 2022 [11]146 yearsFBMCNoOCNoAcetazolami (250 mg ×2)
Rajabi, 2023 [40]14 yearsFUMCNon suspGSWDYes
Present case report16 yearsMUMCSuspSOFYesAcetazolami(250 mg)
Overall4315 days–82 years23 M
20 F
28 U
15 B
34 MC
9 MEC
5 Yes
5 Susp
25 Non susp
4 No
25 OC
6 ORD
6 GSWD
4 SOF
22 Yes
21 No
7 Yes
4 No
7 NF or suspected
3 other
30 no
IP: interventional procedures; M: male; F: female; NOS: not otherwise specified; U: unilateral; Ich: intracranial hypertension; Susp: suspected; Non susp: non suspected; OC: optic canal; ORD: orbital roof defect; SOF: superior orbital fissure; GSWD: greater sphenoidal wing defect; MC: meningocele; MEC: meningoencephalocele.
Table 2. Characteristics of patients included in the systematic review.
Table 2. Characteristics of patients included in the systematic review.
N (% or CI)
Sex
    Male23 (53.5%)
    Female20 (46.5%)
Median age in years (range)27.7 (20.3–35.1)
ICH assessment
    LP > 200 mmH2O5 (11.6%)
    Suspected5 (11.6%)
    Non suspected25 (58.1%)
    No4 (9.3%)
    Unknown4 (9.3%)
Surgery or interventional procedure
    Surgery21 (48.8%)
    Craniofacial surgery    15 (71.4%)
    Cystoperitoneal shunting    2 (9.5%)
    Transpalpebral surgery    1 (4.8%)
    Other3 (14.3%)
    Interventional procedure1 (2.4%)
    No21 (48.8%)
Herniation point
    Optic canal25 (58.1%)
    Unilateral    15 (60.0%)
    Bilateral    10 (40.0%)
    Orbital roof defect6 (13.9%)
    Greater sphenoidal wing defect6 (13.9%)
    Superior orbital fissure4 (9.3%)
    Unknown2 (4.8%)
Medical treatment for ICH (Acetazolamide)
    Yes7 (16.3%)
    No5 (11.5%)
    Unknown31 (72.2%)
Outcome for ocular function
    No deficit (diplopia or visual acuity)22 (51.2%)
    Permanent deficit (diplopia or visual acuity)15 (34.9%)
    Unknown6 (13.9%)
Associated medical conditions
    NF1 or suspected NF17 (16.3%)
    Others3 (7.0%)
    None33 (76.7%)
Median follow-up (months)9.9 (reported only in 14 cases)
ICH: intracranial hypertension; LP: lumbar puncture; CI: confidence interval; NF1: neurofibromatosis 1.
Table 3. Analysis of symptoms, intracranial hypertension, and association with neurofibromatosis 1 with the herniation point of the cephalocele.
Table 3. Analysis of symptoms, intracranial hypertension, and association with neurofibromatosis 1 with the herniation point of the cephalocele.
Herniation PointSymptomsICHNF1
Optic canal (25)18 (72.0%) Loss of vision
8 (32.0%) Headache
2 (8.0%) Orbital content displacement
2 (8.0%) Proptosis
2 (8.0%) Orbital pain
1 (4.0%) Asymptomatic
5 (20.0%) PL > 200 mmH2O
4 (16.0%) suspected
14 (56.0%) Not suspected
2 (8.0%) No
4 (16.0%) Yes
21 (84.0%) No
Orbital roof defect (6)3 (50%) Periorbital swelling
3 (50.0%) Proptosis
3 (50%) Orbital pulsation
1 (16.7%) Loss of vision
1 (16.7%) Orbital content displacement
1 (16.7%) Headache
1 (16.7%) Liquorrea
4 (66.7%) Not suspected
2 (33.3%) Unknown
6 (100%) No
Greater sphenoidal wing defect (6)5 (83.3%) Proptosis
3 (50%) Orbital pulsation
3 (50%) Orbital content displacement
2 (33.3%) loss of vision
1 (16.7%) Orbital pain
4 (66.7%) Not suspected
1 (16.7%) No
1 (16.7%) Unknown
1 (16.7%) Yes
2 (33.3%) Suspected
Superior orbital fissure (4)3 (75.0%) Periorbital swelling
2 (50.0%) Proptosis
1 (25.0%) Orbital content displacement
1 (25.0%) Asymptomatic
2 (50.0%) Not suspected
1 (25.0%) Suspected
1 (25.0%) Unknown
4 (100%) No
ICH: intracranial hypertension; NF1: neurofibromatosis type 1.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gaudioso, P.; Biancoli, E.; Battistuzzi, V.; Concheri, S.; Saccardo, T.; Franchella, S.; Contro, G.; Taboni, S.; Zanoletti, E.; Causin, F.; et al. A Pathophysiological Approach to Spontaneous Orbital Meningoceles: Case Report and Systematic Review. J. Pers. Med. 2024, 14, 465. https://doi.org/10.3390/jpm14050465

AMA Style

Gaudioso P, Biancoli E, Battistuzzi V, Concheri S, Saccardo T, Franchella S, Contro G, Taboni S, Zanoletti E, Causin F, et al. A Pathophysiological Approach to Spontaneous Orbital Meningoceles: Case Report and Systematic Review. Journal of Personalized Medicine. 2024; 14(5):465. https://doi.org/10.3390/jpm14050465

Chicago/Turabian Style

Gaudioso, Piergiorgio, Elia Biancoli, Veronica Battistuzzi, Stefano Concheri, Tommaso Saccardo, Sebastiano Franchella, Giacomo Contro, Stefano Taboni, Elisabetta Zanoletti, Francesco Causin, and et al. 2024. "A Pathophysiological Approach to Spontaneous Orbital Meningoceles: Case Report and Systematic Review" Journal of Personalized Medicine 14, no. 5: 465. https://doi.org/10.3390/jpm14050465

APA Style

Gaudioso, P., Biancoli, E., Battistuzzi, V., Concheri, S., Saccardo, T., Franchella, S., Contro, G., Taboni, S., Zanoletti, E., Causin, F., Nico, L., Gabrieli, J. D., Maroldi, R., Nicolai, P., & Ferrari, M. (2024). A Pathophysiological Approach to Spontaneous Orbital Meningoceles: Case Report and Systematic Review. Journal of Personalized Medicine, 14(5), 465. https://doi.org/10.3390/jpm14050465

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop